Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a **pseudogene** homologous to MT-ATP8, the mitochondrial gene encoding a subunit of the mitochondrial F-type ATP synthase complex (Complex V), which is essential for cellular energy production through oxidative phosphorylation[1][3]. However, as a pseudogene, ENSG00000242246 does **not encode a functional protein product**, is not integrated into the mitochondrial genome, and does not contribute to ATP synthesis or oxidative phosphorylation[4][6][5]. Pseudogenes are typically nonfunctional segments of DNA that arise by gene duplication or retrotransposition and acquire disabling mutations; in rare cases, their transcribed RNAs may play a regulatory role, but this has not been demonstrated for this locus[2][6]. Key point: This locus is a **non-functional pseudogene**, not a canonical therapeutic or diagnostic target, and not an expressed gene product relevant for small molecule or biologic intervention. Its annotation could lead to confusion if users are seeking bona fide targets involved in ATP synthesis or mitochondrial disease[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded ATP synthase 8 pseudogene (MT-ATP8 pseudogene).